Literature DB >> 14623657

Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial.

Justin A Paoloni1, Richard C Appleyard, Janis Nelson, George A C Murrell.   

Abstract

BACKGROUND: Extensor tendinosis ("tennis elbow") is a degenerative overuse tendinopathy of the wrist extensors at their attachment to the lateral humeral epicondyle. No treatment has been universally successful. Topical application of nitric oxide has been used effectively to treat fractures and cutaneous wounds in animal models, presumably by stimulation of collagen synthesis in fibroblasts.
PURPOSE: To determine whether topical nitric oxide can improve outcome of patients with extensor tendinosis. STUDY
DESIGN: Prospective, randomized, double-blinded clinical trial.
METHODS: Eighty-six patients with extensor tendinosis were randomized into two equal groups; both were instructed to perform a standard tendon rehabilitation program. One group received an active glyceryl trinitrate transdermal patch, and the other group received a placebo patch.
RESULTS: Patients in the glyceryl trinitrate group had significantly reduced elbow pain with activity at 2 weeks, reduced epicondylar tenderness at 6 and 12 weeks, and an increase in wrist extensor mean peak force and total work at 24 weeks. At 6 months, 81% of treated patients were asymptomatic during activities of daily living, compared with 60% of patients who had tendon rehabilitation alone.
CONCLUSIONS: Application of topical nitric oxide improved early pain with activity, late functional measures, and outcomes of patients with extensor tendinosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623657     DOI: 10.1177/03635465030310062901

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  31 in total

Review 1.  What do we mean by the term "inflammation"? A contemporary basic science update for sports medicine.

Authors:  A Scott; K M Khan; C R Roberts; J L Cook; V Duronio
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

Review 2.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 3.  Lateral epicondylitis in tennis: update on aetiology, biomechanics and treatment.

Authors:  Thomas De Smedt; Andy de Jong; Wim Van Leemput; Dossche Lieven; Francis Van Glabbeek
Journal:  Br J Sports Med       Date:  2007-07-06       Impact factor: 13.800

4.  Autologous Blood Injection Works for Recalcitrant Lateral Epicondylitis.

Authors:  Bora Bostan; Orhan Balta; Murat Aşçı; Kürşad Aytekin; Enes Eser
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

Review 5.  Endothelial dysfunction and tendinopathy: how far have we come?

Authors:  R Papalia; L Moro; F Franceschi; E Albo; S D'Adamio; A Di Martino; G Vadalà; C Faldini; V Denaro
Journal:  Musculoskelet Surg       Date:  2013-08-02

6.  [Conservative treatment of chronic tendinopathies].

Authors:  P Diehl; H Gollwitzer; J Schauwecker; T Tischer; L Gerdesmeyer
Journal:  Orthopade       Date:  2014-02       Impact factor: 1.087

7.  Nitric oxide is negatively correlated to pain during acute inflammation.

Authors:  May Hamza; Xiao-Min Wang; Tongtong Wu; Jaime S Brahim; Janet S Rowan; Raymond A Dionne
Journal:  Mol Pain       Date:  2010-09-15       Impact factor: 3.395

Review 8.  Using nitric oxide to treat tendinopathy.

Authors:  George A C Murrell
Journal:  Br J Sports Med       Date:  2007-02-08       Impact factor: 13.800

Review 9.  Treatment of tendinopathy: what works, what does not, and what is on the horizon.

Authors:  Brett M Andres; George A C Murrell
Journal:  Clin Orthop Relat Res       Date:  2008-04-30       Impact factor: 4.176

Review 10.  Regulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management.

Authors:  George Groeneweg; Frank J P M Huygen; Terence J Coderre; Freek J Zijlstra
Journal:  BMC Musculoskelet Disord       Date:  2009-09-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.